10-QPeriod: Q1 FY2025

COGNIZANT TECHNOLOGY SOLUTIONS CORP Quarterly Report for Q1 Ended Mar 31, 2025

Filed May 1, 2025For Securities:CTSH

Summary

Cognizant Technology Solutions Corporation (CTSH) reported a solid first quarter for 2025, demonstrating robust top-line growth and improved profitability. Revenues increased by 7.5% year-over-year to $5,115 million, driven by strong performance in its Health Sciences and Financial Services segments, as well as contributions from recent acquisitions which added approximately 400 basis points to growth. The company also saw a notable improvement in its operational efficiency, with Income from Operations increasing by 22.7% to $853 million and the Operating Margin expanding by 210 basis points to 16.7%. Key drivers of this improved profitability include cost savings from the NextGen program, operational efficiencies, and favorable foreign currency movements. While the company experienced an increase in voluntary attrition and a slight increase in Days Sales Outstanding (DSO), these were offset by strategic investments and ongoing client demand for digital transformation and AI-enhanced services. Cognizant continues to navigate a dynamic market, emphasizing its investment in AI capabilities to drive future growth and deliver value to its clients.

Financial Highlights

49 data points
Beta

Revenue

$5.12B

Net Income

$663.00M

13.0% Net Margin

EPS (Diluted)

$1.34

Total Assets

$19.97B

Cash & Equivalents

$1.98B

Free Cash Flow

$323.00M

Financial Statements
Beta
Revenue$5.12B
SG&A Expenses$791.00M
Operating Income$853.00M
Net Income$663.00M
EPS (Basic)$1.34
EPS (Diluted)$1.34
Shares Outstanding (Basic)494.00M
Shares Outstanding (Diluted)495.00M

Key Highlights

  • 1Revenue grew 7.5% year-over-year to $5,115 million, with constant currency growth of 8.2%, aided by acquisitions contributing 400 basis points.
  • 2Income from Operations surged 22.7% to $853 million, and Operating Margin expanded by 210 basis points to 16.7%.
  • 3Diluted Earnings Per Share (EPS) increased by 21.8% to $1.34.
  • 4The Health Sciences and Financial Services segments showed strong growth, while the Products and Resources segment also benefited significantly from recent acquisitions.
  • 5The company reported a gain of $62 million from the sale of an office complex in India, positively impacting GAAP operating margin.
  • 6Voluntary attrition for tech services increased to 15.8% year-over-year, while Days Sales Outstanding (DSO) rose to 81 days.
  • 7Cognizant is actively investing in AI capabilities, including GenAI, to meet client demands and drive future growth.

Frequently Asked Questions

Cognizant's revenue growth of 7.5% was primarily driven by strong performance in its Health Sciences and Financial Services segments, along with significant contributions from recent acquisitions, which accounted for approximately 400 basis points of the overall growth. Growth was also bolstered by integrated offerings involving the resale of third-party products.

Profitability improved due to a combination of factors including net savings generated from the NextGen program, operational efficiencies, and favorable foreign currency exchange rate movements. A $62 million gain from the sale of an office complex also positively impacted the GAAP operating margin.

Key challenges include an increase in voluntary attrition for tech services, a rise in Days Sales Outstanding (DSO), and uncertainty related to the global economy which may affect client demand. The company also faces risks associated with the competitive and rapidly evolving AI market and potential demand reduction for certain services due to automation.

Cognizant is making significant investments in its AI capabilities, including Generative AI, to meet client needs and leverage AI in a flexible, secure, scalable, and responsible manner. The company acknowledges that the evolution of AI may reduce demand for some current services and impact pricing.